Duncker Streett & Co’s ResMed RMD Stock Holding History

Duncker Streett & Co’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6K	Hold	80	–	–	﹤0.01%	397
2026 Q1	$18K	Hold	80	–	–	﹤0.01%	394
2025 Q4	$19.3K	Hold	80	–	–	﹤0.01%	383
2025 Q3	$21.9K	Hold	80	–	–	﹤0.01%	385
2025 Q2	$20.6K	Hold	80	–	–	﹤0.01%	385
2025 Q1	$17.9K	Hold	80	–	–	﹤0.01%	385
2024 Q4	$18.3K	Hold	80	–	–	﹤0.01%	404
2024 Q3	$19.5K	Hold	80	–	–	﹤0.01%	380
2024 Q2	$15.3K	Hold	80	–	–	﹤0.01%	391
2024 Q1	$15.8K	Hold	80	–	–	﹤0.01%	391
2023 Q4	$13.8K	Hold	80	–	–	﹤0.01%	397
2023 Q3	$11.8K	Hold	80	–	–	﹤0.01%	400
2023 Q2	$17.5K	Hold	80	–	–	﹤0.01%	373
2023 Q1	$17.5K	Hold	80	–	–	﹤0.01%	367
2022 Q4	$16.6K	Hold	80	–	–	﹤0.01%	385
2022 Q3	$17K	Hold	80	–	–	﹤0.01%	369
2022 Q2	$17K	Hold	80	–	–	﹤0.01%	377
2022 Q1	$19K	Hold	80	–	–	﹤0.01%	383
2021 Q4	$21K	Hold	80	–	–	﹤0.01%	407
2021 Q3	$21K	Hold	80	–	–	﹤0.01%	401
2021 Q2	$20K	Hold	80	–	–	﹤0.01%	409
2021 Q1	$16K	Hold	80	–	–	﹤0.01%	418
2020 Q4	$17K	Hold	80	–	–	﹤0.01%	421
2020 Q3	$14K	Sell	80 -68	-46%	-$12.6K	﹤0.01%	411
2020 Q2	$28K	Hold	148	–	–	0.01%	360
2020 Q1	$22K	Hold	148	–	–	0.01%	384
2019 Q4	$23K	Buy	+148	New	+$21.3K	﹤0.01%	417
2019 Q3	–	Sell	-80	Closed	-$10K	–	440
2019 Q2	$10K	Hold	80	–	–	﹤0.01%	490
2019 Q1	$8K	Sell	80 -240	-75%	-$24.8K	﹤0.01%	507
2018 Q4	$36K	Sell	320 -150	-32%	-$16.1K	0.01%	387
2018 Q3	$54K	Hold	470	–	–	0.01%	380
2018 Q2	$49K	Hold	470	–	–	0.01%	388
2018 Q1	$46K	Hold	470	–	–	0.01%	393
2017 Q4	$40K	Hold	470	–	–	0.01%	417
2017 Q3	$36K	Sell	470 -400	-46%	-$30.6K	0.01%	420
2017 Q2	$68K	Hold	870	–	–	0.02%	356
2017 Q1	$63K	Hold	870	–	–	0.02%	373
2016 Q4	$54K	Hold	870	–	–	0.02%	380
2016 Q3	$56K	Hold	870	–	–	0.02%	354
2016 Q2	$55K	Hold	870	–	–	0.02%	347
2016 Q1	$50K	Sell	870 -3,511	-80%	-$199K	0.02%	356
2015 Q4	$235K	Sell	4,381 -1,280	-23%	-$72.2K	0.09%	218
2015 Q3	$288K	Sell	5,661 -1,500	-21%	-$80.7K	0.11%	194
2015 Q2	$404K	Sell	7,161 -433	-6%	-$27.3K	0.14%	167
2015 Q1	$545K	Hold	7,594	–	–	0.18%	140
2014 Q4	$426K	Hold	7,594	–	–	0.14%	169
2014 Q3	$374K	Sell	7,594 -4,677	-38%	-$238K	0.13%	183
2014 Q2	$621K	Buy	12,271 +401	+3%	+$19.9K	0.2%	136
2014 Q1	$530K	Sell	11,870 -4,680	-28%	-$210K	0.19%	143
2013 Q4	$779K	Buy	16,550 +6,400	+63%	+$324K	0.28%	103
2013 Q3	$536K	Sell	10,150 -3,500	-26%	-$170K	0.22%	131
2013 Q2	$616K	Buy	+13,650	New	+$648K	0.24%	126

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Duncker Streett & Co's RMD Position: Q2 2026 in Review

Duncker Streett & Co held its ResMed (RMD) position steady in Q2 2026 at 80 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #397.

Duncker Streett & Co first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $779K in Q4 2013. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Duncker Streett & Co held 80 shares of ResMed worth $15.6K as of Q2 2026.
Duncker Streett & Co left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #397 holding.
Duncker Streett & Co first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
Duncker Streett & Co's ResMed position peaked at $779K in Q4 2013.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.